Laboratorios Farmaceuticos ROVI Cash Flow Conversion Efficiency

Latest as of September 2025: 0.116x

Laboratorios Farmaceuticos ROVI cash flow conversion efficiency. Based on the latest financial reports, Laboratorios Farmaceuticos ROVI (ROVI) has a cash flow conversion efficiency ratio of 0.116x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€73.37 Million ≈ $85.78 Million USD) by net assets (€632.80 Million ≈ $739.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Laboratorios Farmaceuticos ROVI (2006–2024)

Cash flow conversion efficiency of Laboratorios Farmaceuticos ROVI from 2006 to 2024. This chart illustrates how Laboratorios Farmaceuticos ROVI's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ROVI share price today for real-time trading data and today's change.

Laboratorios Farmaceuticos ROVI Cash Flow Conversion Ratio Explained

Laboratorios Farmaceuticos ROVI cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Laboratorios Farmaceuticos ROVI Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Farmaceuticos ROVI ranked by their cash flow conversion efficiency. Also see Laboratorios Farmaceuticos ROVI market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Indofood Cbp Sukses Makmur Tbk JK:ICBP	0.033x
Kulicke and Soffa Industries Inc F:KU1	0.050x
DMG MORI AKTIENGESELLSCHAFT XETRA:GIL	0.012x
Baic Bluepark New Energy Technology SHG:600733	-0.273x
Figure Technology Solutions, Inc. Class A Common Stock NASDAQ:FIGR	-1.593x
Kontoor Brands Inc NYSE:KTB	0.121x
Dairy Farm International Holdings Limited F:DFA1	1.058x
Pampa Energía S.A F:9PAA	-0.061x

Annual Cash Flow Conversion Efficiency for Laboratorios Farmaceuticos ROVI (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Farmaceuticos ROVI from 2006 to 2024. Review Laboratorios Farmaceuticos ROVI free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€581.54 Million ≈ $679.88 Million	€138.28 Million ≈ $161.66 Million	0.238x	+14.11%
2023-12-31	€543.49 Million ≈ $635.40 Million	€113.25 Million ≈ $132.40 Million	0.208x	-54.28%
2022-12-31	€521.38 Million ≈ $609.55 Million	€237.60 Million ≈ $277.78 Million	0.456x	+43.62%
2021-12-31	€470.98 Million ≈ $550.62 Million	€149.44 Million ≈ $174.71 Million	0.317x	+152.96%
2020-12-31	€373.70 Million ≈ $436.89 Million	€46.88 Million ≈ $54.80 Million	0.125x	+547.14%
2019-12-31	€322.39 Million ≈ $376.90 Million	€-9.04 Million ≈ $-10.57 Million	-0.028x	-194.53%
2018-12-31	€287.47 Million ≈ $336.08 Million	€8.53 Million ≈ $9.97 Million	0.030x	-68.47%
2017-12-31	€191.69 Million ≈ $224.10 Million	€18.04 Million ≈ $21.09 Million	0.094x	-62.09%
2016-12-31	€183.41 Million ≈ $214.42 Million	€45.53 Million ≈ $53.22 Million	0.248x	+39.17%
2015-12-31	€164.78 Million ≈ $192.65 Million	€29.39 Million ≈ $34.36 Million	0.178x	+22.88%
2014-12-31	€158.47 Million ≈ $185.27 Million	€23.00 Million ≈ $26.89 Million	0.145x	-29.67%
2013-12-31	€144.46 Million ≈ $168.89 Million	€29.82 Million ≈ $34.86 Million	0.206x	+33.06%
2012-12-31	€126.45 Million ≈ $147.83 Million	€19.61 Million ≈ $22.93 Million	0.155x	+39.39%
2011-12-31	€113.98 Million ≈ $133.26 Million	€12.68 Million ≈ $14.83 Million	0.111x	-45.31%
2010-12-31	€104.13 Million ≈ $121.74 Million	€21.19 Million ≈ $24.77 Million	0.203x	+51.20%
2009-12-31	€71.50 Million ≈ $83.59 Million	€9.62 Million ≈ $11.25 Million	0.135x	-48.51%
2008-12-31	€48.44 Million ≈ $56.63 Million	€12.66 Million ≈ $14.80 Million	0.261x	+1079.12%
2007-12-31	€51.92 Million ≈ $60.70 Million	€1.15 Million ≈ $1.35 Million	0.022x	-92.59%
2006-12-31	€25.81 Million ≈ $30.17 Million	€7.72 Million ≈ $9.02 Million	0.299x	--

About Laboratorios Farmaceuticos ROVI

MC:ROVI Spain Drug Manufacturers - Specialty & Generic

Market Cap

$3.74 Billion

€3.20 Billion EUR

Market Cap Rank

#4151 Global

#34 in Spain

Share Price

€62.55

Change (1 day)

+1.62%

52-Week Range

€53.65 - €85.55

All Time High

€90.54